These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28497674)

  • 1. The Vespid Allergy Quality of Life Questionnaire - cultural adaptation and translation to Portuguese.
    Silva D; Pereira AM; Santos N; Amaral L; Delgado L; Oude Elberink JN; Coimbra A
    Eur Ann Allergy Clin Immunol; 2017 May; 49(3):114-121. PubMed ID: 28497674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-life in insect venom allergy: validation of the Turkish version of the "Vespid Allergy Quality of Life Questionnaire" (VQLQ-T).
    Sin BA; Öztuna D; Gelincik A; Gürlek F; Baysan A; Sin AZ; Aydın Ö; Mısırlıgil Z
    Springerplus; 2016; 5():583. PubMed ID: 27247880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the quality of life in subjects with a history of severe anaphylactic reaction to the Hymenoptera venom.
    Nowak N; Bazan-Socha S; Pulka G; Pełka K; Latra P
    Pneumonol Alergol Pol; 2015; 83(5):352-8. PubMed ID: 26378996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-Sectional Validation of a Quality of Life Questionnaire in Spanish for Patients Allergic to Hymenoptera Venom.
    Armisén M; Guspi R; Alfaya T; Cruz S; Fernández S; Domínguez-Noche C; Alonso A; Dalmau G; Marqués L; Vega A
    J Investig Allergol Clin Immunol; 2015; 25(3):176-82. PubMed ID: 26182683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quality-of-life Study in Patients with Anaphylaxis to Hymenoptera Venom in Iran.
    Bemaniyan MH; Heidari M; Tavakol M; Nabavi M; Ramezani Kashal F; Gholami M; Bemaniyan B
    Iran J Allergy Asthma Immunol; 2024 Feb; 23(1):59-68. PubMed ID: 38485910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-of-life in wasp venom allergy - validation of the German version of the "Vespid Allergy Quality of Life Questionnaire" (VQLQ-d).
    Fischer J; Feidt A; Giel KE; Martens U; Zipfel S; Biedermann T; Teufel M
    J Dtsch Dermatol Ges; 2011 May; 9(5):379-85. PubMed ID: 21392257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of venom immunotherapy on anxiety level of being re-stung].
    Sacha M; Czarnobilska E; Stobiecki M; Dyga W
    Przegl Lek; 2012; 69(12):1261-5. PubMed ID: 23750435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom.
    Oude Elberink JN; De Monchy JG; Van Der Heide S; Guyatt GH; Dubois AE
    J Allergy Clin Immunol; 2002 Jul; 110(1):174-82. PubMed ID: 12110838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy.
    Eberlein-König B; Schmidt-Leidescher C; Rakoski J; Behrendt H; Ring J
    J Investig Allergol Clin Immunol; 2006; 16(1):5-10. PubMed ID: 16599242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of specific immunotherapy using an ultra-rush induction regimen in bee and wasp allergy.
    Bożek A; Kołodziejczyk K
    Hum Vaccin Immunother; 2018 Feb; 14(2):288-291. PubMed ID: 29106324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
    Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
    J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Component-resolved diagnosis in vespid venom-allergic individuals.
    Galindo-Bonilla PA; Galán-Nieto A; Alfaya-Arias T; García-Rodríguez C; de la Roca-Pinzón F; Feo-Brito F
    Allergol Immunopathol (Madr); 2015; 43(4):398-402. PubMed ID: 25192862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings.
    Oude Elberink JN; van der Heide S; Guyatt GH; Dubois AE
    Clin Exp Allergy; 2009 Jun; 39(6):883-9. PubMed ID: 19364334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous up-dosing of bee and vespid venom immunotherapy is safe.
    Čerpes U; Arzt-Gradwohl L; Schrautzer C; Koch L; Bokanovic D; Laipold K; Tripolt P; Binder B; Sturm GJ
    Allergy; 2020 Mar; 75(3):721-723. PubMed ID: 31595547
    [No Abstract]   [Full Text] [Related]  

  • 16. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.
    Ewan PW; Deighton J; Wilson AB; Lachmann PJ
    Clin Exp Allergy; 1993 Aug; 23(8):647-60. PubMed ID: 8221268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The basophilic histamine liberation test as a diagnostic method in Hymenoptera venom allergy].
    Przybilla B; Ring J; Wielgosch J
    Hautarzt; 1988 Oct; 39(10):662-70. PubMed ID: 2466814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.
    Fiedler C; Miehe U; Treudler R; Kiess W; Prenzel F
    Int Arch Allergy Immunol; 2017; 172(3):167-172. PubMed ID: 28380475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice.
    Engin A; Oktelik FB; Gelincik A; Sin A; Sin BA; Dursun BA; Beyaz S; Gorgulu B; Cetin E; Deniz G
    Allergy Asthma Proc; 2021 Jul; 42(4):350-356. PubMed ID: 34187627
    [No Abstract]   [Full Text] [Related]  

  • 20. Health-related Quality of Life in Hymenoptera Venom Allergy: Validation of the Italian version of the Vespid Allergy Quality of Life Questionnaire (VQLQ-i).
    Mauro M; Bignardi D; Baiardini I; Bonadonna P; Braschi MC; Emiliani F; Guerra L; Liberati S; Olivieri F; Pravettoni V; Preziosi D; Ridolo E; Rivolta F; Martini M; Bilò MB
    Eur Ann Allergy Clin Immunol; 2024 Jan; ():. PubMed ID: 38235503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.